Triall

Triall is a health care and information technology startup based in The Netherlands, founded in 2018. The company's mission is encapsulated in its slogan: "Building towards a future of smarter, safer, and more-efficient clinical trials." Triall offers a comprehensive suite of services and technologies to enhance the efficiency and effectiveness of clinical trials.

One of Triall's key offerings is the Clinical Insights Exchange (CIX), a forthcoming platform that leverages privacy-enhancing technologies to analyze historical clinical trial data, providing valuable insights for study design and planning.

Moreover, Triall provides a range of eClinical solutions characterized by their interoperability and configurability to meet diverse study needs. These solutions encompass advanced web-based, mobile, and wearable integration capabilities, enabling support for decentralized, hybrid, and centralized clinical trials.

Additionally, Triall has established a network of hand-picked CRO partners specializing in various domains, allowing the company to offer end-to-end services covering all essential aspects of clinical trial design and execution.

As of 01 July 2021, Triall secured a significant milestone with a $2.40M Seed Round investment, signaling confidence and support from unannounced investors. With its innovative solutions and solid financial backing, Triall is well-positioned to revolutionize the clinical trial landscape.

Whether it's empowering clinical research professionals or elevating the quality of clinical trials, Triall is dedicated to pushing the boundaries of possibility. For more information, visit their website or contact their team at [email protected].